The location for the first bellwether trials in the Xarelto litigation has been set for the Eastern District of Louisiana—the location where all 550 Xarelto cases have been centralized to expedite pretrial proceedings in a multi-district litigation, or MDL. The Court’s Judge Eldon Fallon has recommended that 50 of those cases be selected for bellwether trials, scheduled to begin in August 2016. The cases all similarly allege that manufacturers of Xarelto, Bayer and Janssen Pharmaceuticals, marketed the drug as being superior to competitor drugs despite the blood thinner’s risk of unstoppable, sometimes fatal bleeding events.
G&E, who is involved in the Bellwether Selection Committee and is leading the Law & Briefing Committee of the Xarelto MDL, has filed numerous complaints on behalf of Xarelto patients and families of lost loved ones who suffered from Bayer and Janssen’s alleged negligence. If you or a loved one experienced complications from taking the drug Xarelto, please call us at 888-207-0382 for a confidential evaluation of your potential claim.